{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:03:54Z","timestamp":1789693434272,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1304800"],"award-info":[{"award-number":["2022YFA1304800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872296"],"award-info":[{"award-number":["81872296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["QY24333"],"award-info":[{"award-number":["QY24333"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cellsig.2026.112817","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:05:25Z","timestamp":1786518325000},"page":"112817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["UNCX\/SIN3A\u2013Mediated H4K8 decrotonylation suppresses FOXO3 to drive TNBC progression and docetaxel resistance"],"prefix":"10.1016","volume":"148","author":[{"given":"Songfu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjia","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cellsig.2026.112817_bb0005","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/jamaoncol.2023.7322","article-title":"PARP inhibitors for breast cancer treatment: a review","volume":"10","author":"Morganti","year":"2024","journal-title":"JAMA Oncol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112817_bb0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s40265-020-01337-5","article-title":"Sacituzumab Govitecan: first approval","volume":"80","author":"Syed","year":"2020","journal-title":"Drugs"},{"issue":"21","key":"10.1016\/j.cellsig.2026.112817_bb0015","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with pembrolizumab in early-stage triple-negative breast cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112817_bb0020","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"23","key":"10.1016\/j.cellsig.2026.112817_bb0025","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1200\/JCO.2017.72.5960","article-title":"Maximizing the clinical benefit of anthracyclines in addition to Taxanes in the adjuvant treatment of early breast Cancer","volume":"35","author":"Curigliano","year":"2017","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112817_bb0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-025-07746-y","article-title":"Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: a systematic review and meta-analysis","volume":"212","author":"Liutti","year":"2025","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.cellsig.2026.112817_bb0040","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.breast.2017.06.023","article-title":"Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC)","volume":"34","author":"Wein","year":"2017","journal-title":"Breast Edinb. Scotl."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112817_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112817_bb0050","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3390\/biomedicines11082159","article-title":"Dev, role of fork-head box genes in breast Cancer: from drug resistance to therapeutic targets","volume":"11","author":"Sadaf","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010090","article-title":"Role of FoxO proteins in cellular response to antitumor agents","volume":"11","author":"Beretta","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-020-0088-2","article-title":"Therapeutic strategies targeting FOXO transcription factors","volume":"20","author":"Calissi","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellsig.2026.112817_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semcancer.2017.11.018","article-title":"The FOXO3-FOXM1 axis: a key cancer drug target and a modulator of cancer drug resistance","volume":"50","author":"Yao","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-021-00571-x","article-title":"PTEN suppresses tumorigenesis by directly dephosphorylating Akt","volume":"6","author":"Bu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112817_bb0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41556-018-0065-8","article-title":"CK1\u03b1 suppresses lung tumour growth by stabilizing PTEN and inducing autophagy","volume":"20","author":"Cai","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"13","key":"10.1016\/j.cellsig.2026.112817_bb0080","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1038\/s41388-020-1181-z","article-title":"SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms","volume":"39","author":"He","year":"2020","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112817_bb0085","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/biof.1411","article-title":"Melatonin protects against a\u03b2-induced neurotoxicity in primary neurons via miR-132\/PTEN\/AKT\/FOXO3a pathway","volume":"44","author":"Zhao","year":"2018","journal-title":"BioFactors (Oxford, England)"},{"key":"10.1016\/j.cellsig.2026.112817_bb0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2019.10.006","article-title":"Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel","volume":"468","author":"Shen","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-018-0856-3","article-title":"Critical role of FOXO3a in carcinogenesis","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112817_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305907","article-title":"NNMT\/1-MNA promote cell-cycle progression of breast cancer by targeting UBC12\/Cullin-1-mediated degradation of P27 proteins","volume":"11","author":"Ma","year":"2024","journal-title":"Adv. Sci."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112817_bb0105","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.7150\/thno.44567","article-title":"TGF-\u03b2 causes docetaxel resistance in prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and protein stabilization","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12929-022-00797-z","article-title":"Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference","volume":"29","author":"Fu","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.cellsig.2026.112817_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2019.11.042","article-title":"FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2\/TR1 signaling pathway","volume":"470","author":"Liu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2026.112817_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1346745","article-title":"Role and regulation of FOXO3a: new insights into breast cancer therapy","volume":"15","author":"Mei","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112817_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215724","article-title":"FOXO3a in cancer drug resistance","volume":"540","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112817_bb0130","article-title":"Protein lysine crotonylation in cellular processions and disease associations","volume":"11","author":"Zhao","year":"2023","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0135","article-title":"P300 regulates histone crotonylation and preimplantation embryo development","volume":"15","author":"Gao","year":"2024","journal-title":"Nat. Commun."},{"issue":"41","key":"10.1016\/j.cellsig.2026.112817_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202507635","article-title":"Hepatic CBP\/p300 orchestrate amino acid-driven gluconeogenesis through histone crotonylation","volume":"12","author":"Sheng","year":"2025","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112817_bb0145","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cr.2017.68","article-title":"Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription","volume":"27","author":"Wei","year":"2017","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112817_bb0150","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2017.07.011","article-title":"Chromodomain protein CDYL acts as a crotonyl-CoA hydratase to regulate histone crotonylation and spermatogenesis","volume":"67","author":"Liu","year":"2017","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112817_bb0155","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.stem.2020.12.009","article-title":"Histone crotonylation promotes mesoendodermal commitment of human embryonic stem cells","volume":"28","author":"Fang","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112817_bb0160","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","article-title":"Histone post-translational modifications - cause and consequence of genome function","volume":"23","author":"Mill\u00e1n-Zambrano","year":"2022","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0165","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1038\/s41467-024-47315-3","article-title":"Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1\u03b2-dependent macrophage activation and tubular cell senescence","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0170","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1038\/s41467-024-50121-6","article-title":"Targeting the transmembrane cytokine co-receptor neuropilin-1 in distal tubules improves renal injury and fibrosis","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112817_bb0175","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/CIRCRESAHA.124.324733","article-title":"Crotonylation of NAE1 modulates cardiac hypertrophy via gelsolin neddylation","volume":"135","author":"Ju","year":"2024","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112817_bb0180","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/CIRCULATIONAHA.120.049438","article-title":"Short-chain enoyl-CoA hydratase mediates histone crotonylation and contributes to cardiac homeostasis","volume":"143","author":"Tang","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0185","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1038\/s41467-024-51232-w","article-title":"Hypoxia-induced downregulation of PGK1 crotonylation promotes tumorigenesis by coordinating glycolysis and the TCA cycle","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0190","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","article-title":"Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112817_bb0195","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41419-023-06164-6","article-title":"Crotonylated BEX2 interacts with NDP52 and enhances mitophagy to modulate chemotherapeutic agent-induced apoptosis in non-small-cell lung cancer cells","volume":"14","author":"Mu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112817_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13759","article-title":"Crotonylation of MCM6 enhances chemotherapeutics sensitivity of breast cancer via inducing DNA replication stress","volume":"58","author":"Song","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.cellsig.2026.112817_bb0205","article-title":"Characterization of paralogous uncx transcription factor encoding genes in zebrafish","volume":"721S","author":"Nittoli","year":"2019","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112817_bb0210","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.mcn.2010.07.013","article-title":"Uncx regulates proliferation of neural progenitor cells and neuronal survival in the olfactory epithelium","volume":"45","author":"Sammeta","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1677\/jme.1.01831","article-title":"Neurohypophysial dysmorphogenesis in mice lacking the homeobox gene Uncx4.1","volume":"36","author":"Asbreuk","year":"2006","journal-title":"J. Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112817_bb0220","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ydbio.2009.06.006","article-title":"Lack of the mesodermal homeodomain protein MEOX1 disrupts sclerotome polarity and leads to a remodeling of the cranio-cervical joints of the axial skeleton","volume":"332","author":"Skuntz","year":"2009","journal-title":"Dev. Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112817_bb0225","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/dvdy.23945","article-title":"Characterization of pax1, pax9, and uncx sclerotomal genes during Xenopus laevis embryogenesis","volume":"242","author":"S\u00e1nchez","year":"2013","journal-title":"Dev. Dyn."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112817_bb0230","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1158\/1078-0432.CCR-17-1222","article-title":"A panel of novel detection and prognostic methylated DNA markers in primary non-small cell lung Cancer and serum DNA","volume":"23","author":"Ooki","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112817_bb0235","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3324\/haematol.2016.163022","article-title":"Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells","volume":"102","author":"Daniele","year":"2017","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112817_bb0240","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/S0002-9440(10)64500-2","article-title":"Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion","volume":"161","author":"Chatterjee","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112817_bb0245","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1158\/2159-8290.CD-22-0200","article-title":"Proteogenomic markers of chemotherapy resistance and response in triple-negative breast Cancer","volume":"12","author":"Anurag","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellsig.2026.112817_bb0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2017.01.012","article-title":"Circadian gene variants and breast cancer","volume":"390","author":"Reszka","year":"2017","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112817_bb0255","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3390\/ijms22062974","article-title":"The circadian protein PER1 modulates the cellular response to anticancer treatments","volume":"22","author":"Bellet","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112817_bb0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.semcancer.2023.03.003","article-title":"\"time\" for obesity-related cancer: the role of the circadian rhythm in cancer pathogenesis and treatment","volume":"91","author":"Miro","year":"2023","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112817_bb0265","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","article-title":"The challenge of drug resistance in cancer treatment: a current overview","volume":"35","author":"Nikolaou","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112817_bb0270","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of Cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv Pharm Bull"},{"issue":"Suppl. 2","key":"10.1016\/j.cellsig.2026.112817_bb0275","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24","author":"Prat","year":"2015","journal-title":"Breast Edinb. Scotl."},{"key":"10.1016\/j.cellsig.2026.112817_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100754","article-title":"Therapeutic strategies to overcome taxane resistance in cancer","volume":"55","author":"Das","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.cellsig.2026.112817_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101063","article-title":"Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer","volume":"73","author":"Ou","year":"2024","journal-title":"Drug Resist. Updat."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112817_bb0290","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/1535-7163.MCT-13-0918","article-title":"Identification, mechanism of action, and antitumor activity of a small molecule inhibitor of hippo, TGF-\u03b2, and Wnt signaling pathways","volume":"13","author":"Basu","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112817_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113778","article-title":"SIN3A histone deacetylase action counteracts MUS81 to promote stalled fork stability","volume":"43","author":"Mu\u00f1oz","year":"2024","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112817_bb0300","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1172\/JCI94233","article-title":"The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer","volume":"127","author":"Li","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.cellsig.2026.112817_bb0305","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.molcel.2023.05.022","article-title":"Histone H3 lysine 27 crotonylation mediates gene transcriptional repression in chromatin","volume":"83","author":"Liu","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2026.112817_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101173","article-title":"Post-translational modifications in drug resistance","volume":"78","author":"Miao","year":"2025","journal-title":"Drug Resist. Updat."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112817_bb0315","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1158\/0008-5472.CAN-25-3289","article-title":"NSD1-mediated PPAR\u03b3 methylation enhances PTEN activity to suppress glycolysis and tumor progression in endometrial Cancer","volume":"86","author":"Tao","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112817_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216780","article-title":"Unlocking c-MET: a comprehensive journey into targeted therapies for breast cancer","volume":"588","author":"Jabbarzadeh Kaboli","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","article-title":"HER2-targeted therapies - a role beyond breast cancer","volume":"17","author":"Oh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112817_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103756","article-title":"Therapeutic targeting of \"undruggable\" MYC","volume":"75","author":"Llombart","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0335","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-021-00500-y","article-title":"Alternative approaches to target Myc for cancer treatment","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112817_bb0340","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.trecan.2024.03.009","article-title":"A big step for MYC-targeted therapies","volume":"10","author":"Atibalentja","year":"2024","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0345","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellsig.2026.112817_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113774","article-title":"EMT mechanism in breast cancer metastasis and drug resistance: revisiting molecular interactions and biological functions","volume":"155","author":"Hashemi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112817_bb0355","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","article-title":"Cancer drug resistance induced by EMT: novel therapeutic strategies","volume":"95","author":"De Las Rivas","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112817_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157119","article-title":"Docetaxel resistance in breast cancer: current insights and future directions","volume":"26","author":"Postigo-Corrales","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0365","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/s41598-021-81563-3","article-title":"Depletion of Survivin suppresses docetaxel-induced apoptosis in HeLa cells by facilitating mitotic slippage","volume":"11","author":"Han","year":"2021","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112817_bb0370","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1093\/nar\/gkab209","article-title":"Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis","volume":"49","author":"Su","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112817_bb0375","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41467-017-00702-5","article-title":"ZNF516 suppresses EGFR by targeting the CtBP\/LSD1\/CoREST complex to chromatin","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:16:52Z","timestamp":1789690612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826004754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":75,"alternative-id":["S0898656826004754"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112817","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UNCX\/SIN3A\u2013Mediated H4K8 decrotonylation suppresses FOXO3 to drive TNBC progression and docetaxel resistance","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112817"}}